291 related articles for article (PubMed ID: 25417240)
1. The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.
Feuer EJ; Rabin BA; Zou Z; Wang Z; Xiong X; Ellis JL; Steiner JF; Cynkin L; Nekhlyudov L; Bayliss E; Hankey BF
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):265-74. PubMed ID: 25417240
[TBL] [Abstract][Full Text] [Related]
2. Health-care utilization by prognosis profile in a managed care setting: using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC.
Rabin BA; Ellis JL; Steiner JF; Nekhlyudov L; Feuer EJ; Hankey BF; Cynkin L; Bayliss E
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):275-81. PubMed ID: 25417241
[TBL] [Abstract][Full Text] [Related]
3. The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients.
Feuer EJ; Lee M; Mariotto AB; Cronin KA; Scoppa S; Penson DF; Hachey M; Cynkin L; Carter GA; Campbell D; Percy-Laurry A; Zou Z; Schrag D; Hankey BF
Cancer; 2012 Nov; 118(22):5652-62. PubMed ID: 22569947
[TBL] [Abstract][Full Text] [Related]
4. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
5. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer.
Hou G; Zheng Y; Wei D; Li X; Wang F; Tian J; Zhang G; Yan F; Zhu Z; Meng P; Yuan J; Gao M; Li Z; Zhang B; Xing Z; Yuan J
Medicine (Baltimore); 2019 Sep; 98(39):e17197. PubMed ID: 31574827
[TBL] [Abstract][Full Text] [Related]
7. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
8. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
9. Nomograms that predict the survival of patients with adenocarcinoma in villous adenoma of the colorectum: a SEER-based study.
Tang CT; Zeng L; Yang J; Zeng C; Chen Y
BMC Cancer; 2020 Jun; 20(1):608. PubMed ID: 32600342
[TBL] [Abstract][Full Text] [Related]
10. Establishment of prognostic nomogram for elderly colorectal cancer patients: a SEER database analysis.
Yu C; Zhang Y
BMC Gastroenterol; 2020 Oct; 20(1):347. PubMed ID: 33081695
[TBL] [Abstract][Full Text] [Related]
11. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
12. Predicting the absolute risk of dying from colorectal cancer and from other causes using population-based cancer registry data.
Lee M; Cronin KA; Gail MH; Feuer EJ
Stat Med; 2012 Feb; 31(5):489-500. PubMed ID: 22170169
[TBL] [Abstract][Full Text] [Related]
13. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
[TBL] [Abstract][Full Text] [Related]
14. Projecting SEER cancer survival rates to the US: an ecological regression approach.
Mariotto A; Capocaccia R; Verdecchia A; Micheli A; Feuer EJ; Pickle L; Clegg LX
Cancer Causes Control; 2002 Mar; 13(2):101-11. PubMed ID: 11936816
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of prognostic nomograms for patients with metastatic prostate cancer.
Jiang WD; Yuan PC
Int Urol Nephrol; 2019 Oct; 51(10):1743-1753. PubMed ID: 31289983
[TBL] [Abstract][Full Text] [Related]
16. Development of comprehensive nomograms for evaluating overall and cancer-specific survival of laryngeal squamous cell carcinoma patients treated with neck dissection.
Shi X; Hu WP; Ji QH
Oncotarget; 2017 May; 8(18):29722-29740. PubMed ID: 28430613
[TBL] [Abstract][Full Text] [Related]
17. Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.
Sun W; Jiang YZ; Liu YR; Ma D; Shao ZM
Oncotarget; 2016 Apr; 7(15):20496-506. PubMed ID: 26967253
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.
Zhang J; Gong Z; Gong Y; Guo W
Jpn J Clin Oncol; 2019 May; 49(5):438-446. PubMed ID: 30924498
[TBL] [Abstract][Full Text] [Related]
19. Nomograms for predicting long-term overall survival and cancer-specific survival in patients with major salivary gland cancer: a population-based study.
Li Y; Ju J; Liu X; Gao T; Wang Z; Ni Q; Ma C; Zhao Z; Ren Y; Sun M
Oncotarget; 2017 Apr; 8(15):24469-24482. PubMed ID: 28160551
[TBL] [Abstract][Full Text] [Related]
20. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.
Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR
Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
